A response to reimportation

M Newcomer - Structure, 2005 - cell.com
In this issue of Structure, Holmes et al.(2005) describe elements of an innate defense
mechanism that provides mammals a means to restrict bacterial growth. The host protein …

Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study

NC Andreasen, D Liu, S Ziebell… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective Longitudinal structural MRI studies have shown that patients with schizophrenia
have progressive brain tissue loss after onset. Recurrent relapses are believed to play a role …

A meta-analysis of the efficacy of second-generation antipsychotics

JM Davis, N Chen, ID Glick - Archives of general psychiatry, 2003 - jamanetwork.com
Background Consensus panel recommendations regarding choice of an antipsychotic agent
for schizophrenia differ markedly, but most consider second-generation antipsychotics …

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

ND Woodward, SE Purdon, HY Meltzer… - International Journal of …, 2005 - academic.oup.com
Cognitive impairment is a core feature of schizophrenia and a major impediment to social
and vocational rehabilitation. A number of studies have claimed cognitive benefits from …

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

CU Correll, S Leucht, JM Kane - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Based on lower rates of acute extrapyramidal side effects associated with
second-generation antipsychotics, compared to first-generation antipsychotics, and based …

Obesity among those with mental disorders: a National Institute of Mental Health meeting report

DB Allison, JW Newcomer, AL Dunn… - American journal of …, 2009 - Elsevier
The National Institute of Mental Health convened a meeting in October 2005 to review the
literature on obesity, nutrition, and physical activity among those with mental disorders. The …

Efficacy and safety of the 3-month formulation of paliperidone palmitate vs placebo for relapse prevention of schizophrenia: a randomized clinical trial

J Berwaerts, Y Liu, S Gopal, I Nuamah, H Xu… - JAMA …, 2015 - jamanetwork.com
Importance Treatment nonadherence and relapse are common problems in patients with
schizophrenia. The long-acting 3-month formulation of paliperidone palmitate, owing to its …

Adverse effects of atypical antipsychotics: differential risk and clinical implications

PM Haddad, SG Sharma - CNS drugs, 2007 - Springer
Antipsychotic drugs can be of great benefit in a range of psychiatric disorders, including
schizophrenia and bipolar disorder, but all are associated with a wide range of potential …

Recovery from schizophrenia: a concept in search of research

RP Liberman, A Kopelowicz - Psychiatric services, 2005 - Am Psychiatric Assoc
Open Forum a period of sobriety, the use of an operational definition of recovery requires
them to remain abstinent for a defined period and to function with a “clean and sober,” …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

R Australian - Australian & New Zealand Journal of …, 2005 - search.ebscohost.com
Abstract BACKGROUND: The Royal Australian and New Zealand College of Psychiatrists is
co-ordinating the development of clinical practice guidelines (CPGs) in psychiatry, funded …